NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Department of Health and Human Services

Description

The National Institutes of Health (NIH), along with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), plans to issue a funding opportunity for U.S. small businesses in the form of Small Business Innovation Research (SBIR) grants. These include Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. This opportunity is pending the reauthorization of the SBIR program, and applications are not yet being accepted. This advance notice is to give bu…

The National Institutes of Health (NIH), including the following NIH Institutes and Centers (ICs): NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, NCCIH, NCATS, ORIP, NCI and ORWH, along with the Centers for…

Source

Grant ID

FOR-OD-26-001

Agency

Department of Health and Human Services

Subcategory/Subagency

National Institutes of Health

Eligibility

The following categories of applicants are invited to apply:

  • Small businesses
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Eligibility Information
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.
Links
Similar opportunities

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.